Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALING.

Cohavy O, Shih DQ, Doherty TM, Ware CF, Targan SR.

Eur J Microbiol Immunol (Bp). 2011 Mar;1(1):70-79.

2.

Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.

Siakavellas SI, Bamias G.

Inflamm Bowel Dis. 2015 Oct;21(10):2441-52. doi: 10.1097/MIB.0000000000000492. Review.

PMID:
26099067
3.

Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.

Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, Targan SR.

J Immunol. 2005 Apr 15;174(8):4985-90.

4.

Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.

Rout N.

PLoS One. 2016 Jun 16;11(6):e0157407. doi: 10.1371/journal.pone.0157407. eCollection 2016.

5.

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.

Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, de Waal Malefyt R, Pierce RH, McClanahan T, Kastelein RA.

J Exp Med. 2009 Mar 16;206(3):525-34. doi: 10.1084/jem.20081712. Epub 2009 Mar 9.

6.

The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells.

Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR.

J Immunol. 2007 Apr 1;178(7):4033-8.

7.

TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells.

Papadakis KA, Prehn JL, Landers C, Han Q, Luo X, Cha SC, Wei P, Targan SR.

J Immunol. 2004 Jun 1;172(11):7002-7.

8.

Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.

Prehn JL, Mehdizadeh S, Landers CJ, Luo X, Cha SC, Wei P, Targan SR.

Clin Immunol. 2004 Jul;112(1):66-77.

PMID:
15207783
9.

TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammation.

Jin S, Chin J, Seeber S, Niewoehner J, Weiser B, Beaucamp N, Woods J, Murphy C, Fanning A, Shanahan F, Nally K, Kajekar R, Salas A, Planell N, Lozano J, Panes J, Parmar H, DeMartino J, Narula S, Thomas-Karyat DA.

Mucosal Immunol. 2013 Sep;6(5):886-99. doi: 10.1038/mi.2012.124. Epub 2012 Dec 19.

PMID:
23250276
10.

CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.

Walker LJ, Marrinan E, Muenchhoff M, Ferguson J, Kloverpris H, Cheroutre H, Barnes E, Goulder P, Klenerman P.

Front Immunol. 2013 Aug 6;4:223. doi: 10.3389/fimmu.2013.00223. eCollection 2013.

11.

Prostaglandin E2 and IL-23 plus IL-1β differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells.

Barrie A, Khare A, Henkel M, Zhang Y, Barmada MM, Duerr R, Ray A.

Clin Transl Sci. 2011 Aug;4(4):268-73. doi: 10.1111/j.1752-8062.2011.00300.x.

12.

CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner.

Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, de Lara C, Mettke E, Kurioka A, Hansen TH, Klenerman P, Willberg CB.

Eur J Immunol. 2014 Jan;44(1):195-203. doi: 10.1002/eji.201343509. Epub 2013 Oct 1.

13.

Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.

Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, Neisig A, Håkansson K, Dong T, Wagtmann N, Galsgaard ED, Spee P, Braud VM.

J Biol Chem. 2011 Nov 4;286(44):37964-75. doi: 10.1074/jbc.M111.285312. Epub 2011 Sep 19.

14.

Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.

Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8441-6. Epub 2006 May 12.

15.
16.

A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.

Jia LG, Bamias G, Arseneau KO, Burkly LC, Wang EC, Gruszka D, Pizarro TT, Cominelli F.

J Immunol. 2016 Jul 1;197(1):377-86. doi: 10.4049/jimmunol.1502466. Epub 2016 May 27.

PMID:
27233964
17.

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.

Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, Querci V, Fambrini M, Liotta F, Levings MK, Maggi E, Cosmi L, Romagnani S, Annunziato F.

Eur J Immunol. 2010 Aug;40(8):2174-81. doi: 10.1002/eji.200940257.

18.

The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.

Bamias G, Jia LG, Cominelli F.

Curr Opin Gastroenterol. 2013 Nov;29(6):597-602. doi: 10.1097/MOG.0b013e328365d3a2. Review.

PMID:
24100723
19.

Increased frequency of CD4+ cells expressing CD161 in cancer patients.

Iliopoulou EG, Karamouzis MV, Missitzis I, Ardavanis A, Sotiriadou NN, Baxevanis CN, Rigatos G, Papamichail M, Perez SA.

Clin Cancer Res. 2006 Dec 1;12(23):6901-9.

20.

Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma.

González-Hernández Y, Pedraza-Sánchez S, Blandón-Vijil V, del Río-Navarro BE, Vaughan G, Moreno-Lafont M, Escobar-Gutiérrez A.

Scand J Immunol. 2007 Apr;65(4):368-75.

Supplemental Content

Support Center